Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...

Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...

Colorectal cancer, or cancer of the bowel or rectum, has long been associated with older adults. However, in recent years, cases among people under 50 have surged.

CytomX Therapeutics Inc (CTMX) reports encouraging results from its Varseta-M study, with plans for a pivotal trial and expansion into new tumor types.

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody ...

Engaging in at least 150 minutes of moderate-intensity exercise weekly helps regulate hormones, maintain healthy weight, and ...